Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
biolitec is a leading international medical technology company specializing in the development and production of fiber optic laser systems and photodynamic therapy (PDT) solutions. The company is best known for its pharmaceutical product Foscan (temoporfin), a potent photosensitizer approved for the palliative treatment of advanced head and neck squamous cell carcinoma. biolitec provides an integrated therapeutic approach by manufacturing both the laser delivery systems and the specialized drugs required for targeted tissue destruction. Beyond oncology, the company offers minimally invasive laser treatments for vascular diseases, urology, and proctology, including the ELVeS Radial system for varicose veins. Headquartered in Vienna with major research facilities in Jena, Germany, biolitec remains a pioneer in light-based medical interventions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on biolitec research.